ePrescribing Market Size, Share and Trends 2026 to 2035

Revenue, 2025

USD 5.98 Bn

Forecast Year, 2035

USD 59.92 Bn

CAGR, 2026 - 2035

25.92%

Report Coverage

Global

What is the ePrescribing Market Size?

The global ePrescribing market size was calculated at USD 5.98 billion in 2025 and is expected to reach around USD 59.92 billion by 2035. The market is expanding at a solid CAGR of 25.92% over the forecast period 2026 to 2035. The North America ePrescribing market size reached USD 2.17 billion in 2025. The rising adaptation of digitalization and technological adoption in healthcare is boosting the growth of the market.

ePrescribing Market Key Takeaways

• The global ePrescribing market was valued at USD 5.98billionbillion in 2025.
• It is projected to reach USD 59.92 billion by 2035.
• The ePrescribing market is expected to grow at a CAGR of 25.92% from 2026 to 2035.
• North America dominated the market with the largest market share of 46% in 2025.
• Asia Pacific is expected to have the fastest growth during the forecast period.
• By product, the solution segment dominated the market in 2025.
• By delivery mode, the web/cloud-based segment has contributed more than 58% of revenue share in 2025.
• By substances, the controlled substances segment dominated the ePrescribing market in 2025.
• By usage, the handheld segment accounted for the largest market share in 2025.
• By specialties, the sports medicine segment dominated the market with the largest share in 2025.
• By end-user, the hospital segment dominated the ePrescribing market with the largest share in 2025.

What is ePrescribing?

E-prescription is also considered an electronic prescription that allows physicians or prescribers to send error-free, accurate, and understandable prescriptions electronically directly to the pharmacy from the point of care. This system helps in enhancing the quality of patient care. E-prescription is part of the broader digital health and medicine safety framework. It sends the prescription directly to the pharmacist electronically without the need for any paper prescription. This makes prescriptions more efficient, reduces errors, and reduces the need for storing, handling, and maintaining paper prescriptions. The rising adoption of digitalization and automation in several sectors, as well as in the healthcare industry, is driving the growth of the ePrescribing market.

Artificial Intelligence: The Next Growth Catalyst in the ePrescribing Industry

AI is significantly transforming the ePrescribing sector by enhancing medication safety and operational efficiency, shifting the market towards smarter, more proactive workflows. By embedding AI-driven drug interaction alerts, predictive analytics for adherence risk, and natural language processing for free-text orders, these solutions are reducing adverse events and lowering costs.

AI integration facilitates real-time pharmacy benefits and automated prior authorizations, which are key to managing complex, high cost speciality drug prescriptions.

ePrescribing Market Growth Factors

• The increasing adoption of technologies in the healthcare sector and the rising awareness about the spread of infections caused by patients' and physicians' frequent visits to hospitals are driving the adoption of the ePrescribing market.
• The rising global population and the increasing demand for healthcare infrastructure are driving advancements like electronic prescriptions or ePrescribing, and the rising adoption of remote healthcare facilities is driving the growth of the market.
• Rising investment in the expansion of healthcare innovations and facilities, such as an increase in new activities, product launches, product approvals, collaboration, and acquisitions, is accelerating the growth of the market.
• The increasing adoption of electronic health records (EHRs), digitization, artificial intelligence, and automation in the healthcare industry is further contributing to the growth of the ePrescribing market.
• The continuous evolution in demand for healthcare technologies and the investment in further launching products, services, treatment procedures, and medicine by the healthcare industry are driving the growth of the ePrescribing market.

Market Outlook

• Market Growth Overview: The ePrescribing market is expected to grow significantly between 2025 and 2034, driven by the ePrescibing significantly reduces prescription errors, improves medication safety, widespread adoption of EHR integration and digital healthcare adoption, and increases efficiency and workflow optimization.
• Sustainability Trends: Sustainability trends involve eco-directed and sustainable prescribing, digitalization to minimize waste and carbon footprint, and ESG and regulatory compliance.
• Major Investors: Major investors in the market include Surescripts, Oracle, Allscripts Healthcare Solutions, Epic Systems Corporation, and DrFirst.

ePrescribing Market Scope

Market Dynamics

Driver

Rising adoption of healthcare facilities and prescribers

The rising adaptation of electronic prescriptions by the number of healthcare physicians and prescribers is driving the growth of the market. The electronic prescription enables the prescribers to assess the health plan formulator electronically, medical history, and eligibility of the patients at the point of care and helps in transmitting the prescription security to the pharmacists. It helps in improving the safety of the prescription at the time of generation, and it has to be checked at the time of prescribing with the patient's electronic medication profile.

The rising importance of ePrescribing due to medication errors and adverse drug events (ADEs) contributed to over 7000 deaths every year due to drug-related issues, which cost drug-related mortality and morbidity over $77 billion a year. There are several benefits associated with electronic prescription: our patient safety, cost benefits, access to prescription records, enhanced workflow, and others are driving the adoption of ePrescribing by the prescribers or physicians that are contributing to the expansion of the ePrescribing market.

Restraint

High cost

The higher cost associated with the implementation and installation of ePrescribing in healthcare facilities is restraining the growth of the market. The high cost associated with the implementation services, maintenance, integration of ePrescribing with the HER-EMR, support services, and training and education. Additionally, the lack of knowledge about ePrescribing technology is hampering the growth of the ePrescribing market.

Opportunity

Rising adoption of telehealth

The increasing population and the rising demand for efficient healthcare infrastructure drive the demand for healthcare institutes like hospitals, clinics, multispecialty hospitals, and other healthcare institutes. The rising demand for healthcare facilities in the remote and underserved areas of the countries is driving the growth of telehealth . It is the remote healthcare facilities that allows the interaction between the medical practitioners and patients and helping them with the proper treatment plan. The rise in the telehealth is anticipated the growth opportunities for the ePrescribing market.

Segment Insights

Product Insights

The solution segment dominated the ePrescribing market in 2025. The growth of the segment is attributed to the rising adoption of software used in the healthcare industry to streamline patient management and help manage workflow in the pharmacy and hospital settings. Software solutions help maintain the patient's history and prescribe treatment accordingly.

The segment is further divided into the integrated and standalone solutions. Integrated ePrescribing in the healthcare system is used to connect with patients' records, enhancing patients' experience and care. Integrated software solutions are further leveraged into other healthcare workflows, such as optimizing and streamlining healthcare workflows and increasing communication with patients.

Additionally, the standalone software solution is increasing rapidly due to its reduced cost of installation as compared to the integrated solutions. Standalone solutions are suitable for the requirements of the healthcare system and are a great way to start practice in electronic data and workflow management in telehealth with more economic stability.

Delivery Mode Insights

The web/cloud-based segment dominated the ePrescribing market in 2025. The growth of the segment is attributed to the rising adoption of cloud-based solutions by several healthcare practitioners, institutes, and hospitals due to higher efficiency and reduced cost as compared to on-premise solutions. Many physicians or hospitals cannot afford the infrastructure of on-premise systems that accelerate demand for the cloud-based platform segment.

The cloud-based platform is an effective solution for independent healthcare practitioners, small-scale clinics, community hospitals, and doctor's offices that are not willing to pay the higher infrastructure cost associated with the on-premise solution. Thus, the several advantages associated with the cloud-based platform drive the adoption of the segment.

Substances Insights

The controlled substances segment dominated the ePrescribing market in 2025. The growth of the segment is attributed to the increasing adoption of electronic prescribing of controlled substances by the number of physicians because it reduces the burden of physicians for detecting prescription irregularities and fraud. Electronic prescribing of controlled substances helps avoid errors, enhances workflow efficiencies, and allows calls from the pharmacies to clarify the written prescription. The controlled substances have the ability to send error-free, accurate, and understandable controlled substance prescriptions directly to the pharmacy from the healthcare institutes.

Usage Insights

The handheld segment accounted for the largest ePrescribing market share in 2025. The rising use of handheld devices like smartphones allows physicians to make electronic prescriptions for patients. Many handheld devices, such as tablets and smartphones, have mobile applications for the ePrescribing specialties. The rising development in the development of mobile applications for electronic prescription helps physicians and point-of-care prescribe drugs and treatments via handheld devices.

Specialties Insights

The sports medicine segment dominated the ePrescribing market with the largest share in 2025. The rising cases of sports injuries in athletes and the rising adoption of telemedicine by athletes and sports persons due to less time to frequent visits in hospitals drive electronic prescriptions by the sports medicine segment. Additionally, sports medicine physicians require special medication routines based on the sports injuries and demands of the athletes.

The ePrescribing works in sports medicine with the collection of health data by wearable devices, athlete health monitoring systems, and fitness trackers it helps practitioners track the real-time health insights of athletes, performance metrics, and injury risk. Thus, the rising adoption of ePrescribing by sports medicine practitioners is driving the growth of the market.

End-user Insights

The hospital segment dominated the ePrescribing market with the largest share in 2025. Hospitals are among the earliest adopters of digitization in operations. Hospitals have a large number of patient databases, frequent patient visits, and complex workflows that drive the demand for digital solutions to streamline processes and enhance efficiency. Hospital practitioners highly prefer the ePrescribing platform for prescribing accurate drugs directly to pharmacists. It allows the electronic transfer of prescriptions to pharmacists without any type of error or writing mistakes in the prescription. Thus, the rising investment by the hospital authorities in the adaptation of digitalization and automation in the healthcare workflow is driving the growth of the market.

Regional Insights

What is the U.S. ePrescribing Market Size?

The U.S. ePrescribing market size was exhibited at USD 2.06 billion in 2025 and is projected to be worth around USD 21.08 billion by 2035, poised to grow at a CAGR of 26.18% from 2026 to 2035.

North America dominated the market with the largest ePrescribing market share in 2025. The growth of the market is attributed to the early adoption of technological advancements in the healthcare industry. The rising geriatric population and the penetration of chronic diseases are driving the growth of the healthcare infrastructure. The rising cases of infectious illness in the population are restricting frequent visits to hospitals or other healthcare institutions and the adoption of telehealth or telemedicine applications that are driving the growth of the ePrescribing market. Additionally, the rising adoption of electronic prescriptions and digitization in other healthcare operations are further boosting the growth of the region's market.

U.S. ePrescribing Market Trends

The U.S. shift towards cloud-based solutions, ease of integration, and lower installation costs. The regulatory compliance and safety, the regulatory compliance and safety, integration with HER systems, which are used by office-based physicians. Advanced platforms now emphasize real-time benefit checks, offering instant, bi-directional connectivity between providers and pharmacies to check drug coverage. The major focus on electronic prescribing for controlled substances (EPCS) ensures compliance with strict regulations while combating fraud.

Asia Pacific is expected to have the fastest growth during the forecast period. The growth of the market is fueled in the region due to the rising population and the higher demand for developed and well-equipped healthcare infrastructure. The increasing number of patients in healthcare institutes is driving the number of patient databases that make essential adoption of digital solutions like telemedicine, electronic prescription, remote health monitoring , and other applications for catering to the evolving number of patients.

The ePrescribing helps improve the overall operations in the healthcare workflow, as well as efficiency and accuracy in the treatment of patients, with a lower chance of errors in transferring the prescription. Thus, the adoption of ePrescribing solutions by the number of physicians is accelerating the growth of the ePrescribing market across the region.

China ePrescribing Market Trends

China's increasing integration of digitalization of hospital information systems and telemedicine platforms, facilitating seamless remote consultation and prescription delivery, is particularly crucial for managing chronic diseases. The shift towards on-premise systems to cloud-based e-prescribing allows for better scalability, lower upfront costs, and improved accessibility for both clinics and patients. The increasing population, rising smartphone penetration, and the need for efficient, accessible healthcare in urban and rural areas drive the market growth.

What Are the Driving Factors of the ePrescribing Market in Europe?

Europe is expected to grow at a significant rate during the forecast period. Regulatory frameworks and robust healthcare digitization policies contribute to the growth of Europe ePrescribing market. The European Medicines Agency regulatory guidance is focused on patient safety and the minimization of medication errors by using the digital prescribing system. The nations in the region are adopting the incorporation of ePrescribing platforms into national health infrastructure.

UK ePrescribing Market Trends

Adoption of the ePrescribing is still high in the UK because primary healthcare services are highly digitized. Electronic prescription systems are very common in the primary care networks in the National Health Service. Pharmacy services are being incorporated into the Electronic Prescription Service by healthcare providers more often. National programs are aimed at linking hospital systems to community pharmacists in order to facilitate real-time medication reconciliation and enhance cross-border prescription awareness via more widespread European digital health models.

Value Chain Analysis of the ePrescribing Market

• Technology Development & Software Design (R&D)
  This foundational stage involves developing the software engines, including cloud-based platforms, mobile applications, and AI-driven clinical decision support systems (CDSS) that check for drug interactions and allergies.
  Key Players: Epic Systems Corporation, Cerner Corporation, DrFirst, Allscripts Healthcare, LLC, eClinicalWorks, Athenahealth, Inc.
• Regulatory & Compliance Integration
  This stage involves certifying software to meet national and regional standards, ensuring secure data transmission, and obtaining necessary certifications for electronic prescribing of controlled substances (EPCS) and HIPAA compliance.
  Key Players: Drug Enforcement Administration (DEA), Office of the National Coordinator for Health Information Technology (ONC), Surescripts, LLC.
• End-User Adoption
  This stage represents the final application of the technology, where physicians in clinics/hospitals generate prescriptions and pharmacies receive them for dispensing.
  Key Players: Large Hospital Systems, Ambulatory Care Clinics, Independent Pharmacies, and Retail Pharmacy Chains.

ePrescribing Market Companies

• Cerner Corporation (Oracle): Cerner, now part of Oracle Health, provides integrated electronic health record (EHR) systems featuring advanced inpatient (PharmNet) and retail (Etreby) pharmacy modules that enable secure, digital prescription routing.
• Allscripts Healthcare, LL: Allscripts, operating under the Veradigm brand, contributes to the market through integrated ePrescribing capabilities within its acute and ambulatory EHR platforms, allowing for direct transmission of prescriptions and access to patient medication history.
• Epic Systems Corporation: Epic dominates the market with its comprehensive EHR system, which includes the "Willow" pharmacy module for hospitals to streamline medication management from ordering to dispensing.
• DrFirst : DrFirst is a pioneer in ePrescribing, offering Rcopia and the mobile app iPrescribe to provide AI-powered medication management solutions to over 350,000 healthcare professionals and numerous EHR partners.
• Athenahealth: Athenahealth offers a cloud-native, integrated ePrescribing system that enhances workflow efficiency for both independent practices and large healthcare organizations.

Other Major Key Players

• NXGN Management, LLC
• McKesson Corporation
• Surescripts
• Change Healthcare
• Practice Fusion, Inc.
• Networking Technology, Inc. (RXNT)

Segments Covered in the Report

By Product

• Solutions
  • Integrated solutions
  • Standard solutions
• Services
  • Support
  • Implementing
  • Training
  • Network

By Delivery Mode

• Web-cloud Based
• On-premise

By Substances

• Controlled Substances
• Non-Controlled Substances

By Usage

• Handheld
• Computer-based Devices

By Specialties

• Sport Medicine
• Oncology
• Neurology
• Cardiology
• Others

By End-user

• Hospitals
• Office-based Physicians
• Pharmacy
• Others

By Geography

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East & Africa